ASX200 Index Rebalance Preview: Three Potential Changes & Some Close Names
We see three potential changes to the ASX200 in the March review while there are another two close adds/deletes. High short interest on the...
627 Views
ASX200 Index Review - A Handful of Changes
S&P Dow Jones Indices announced changes to the S&P/ASX 200 (AS51 INDEX) today. The changes are effective at the open of trading on 22 June...
706 Views
Australia Short Interest - August in Review
Of the 134 companies that reported annual results in August, 65% missed their targets on the top line and just over half reported a rise in profits...
550 Views
Raising FVE for Mesoblast After Adjusting for AUD as We Await 180 Day Survival Data in AGvHD
We are raising our fair value estimate for no-moat Mesoblast Ltd (MSB AU) to AUD 2.90 from AUD 2.60 previously, after adjusting for the recent...
528 Views
Mesoblast Books First-Half Profit and Moves Closer to FDA Approval in Pediatric AGvHD
No-moat Mesoblast Ltd (MSB AU) achieved a financial milestone in the first six months of fiscal 2018 by posting a maiden net profit after tax of...
193 Views